A 38-year-old woman from Delhi with a 10-year history of pruritus and fatigue presents with jaundice for 2 weeks. She denies alcohol use, fever, or abdominal pain. On examination, she has xanthomas on her eyelids and elbows, hepatomegaly, and no splenomegaly. Laboratory investigations: total bilirubin 5.4 mg/dL (direct 4.2 mg/dL), AST 120 U/L, ALT 145 U/L, ALP 420 U/L, GGT 380 U/L, albumin 3.2 g/dL. Abdominal ultrasound shows normal bile ducts and no stones. Serum anti-mitochondrial antibody (AMA) is positive at 1:640. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Primary Biliary Cholangitis (PBC) ### Classic Presentation of PBC **Key Point:** The combination of chronic pruritus, xanthomas, positive AMA, and cholestatic liver biochemistry in a middle-aged woman is pathognomonic for primary biliary cholangitis. **High-Yield:** PBC is a chronic autoimmune cholestasis affecting predominantly women (9:1 female predominance). The disease progresses from asymptomatic cholestasis to cirrhosis over 10–20 years. ### Diagnostic Criteria for PBC | Criterion | Finding in This Patient | Status | |-----------|-------------------------|--------| | **AMA positivity** | 1:640 (high titer) | ✓ Diagnostic | | **Cholestatic pattern** | ALP 420, GGT 380 | ✓ Confirms biliary origin | | **Normal bile ducts** | On ultrasound | ✓ Excludes obstruction | | **Female, middle-aged** | 38-year-old woman | ✓ Typical demographics | | **Chronic pruritus** | 10-year history | ✓ Pathognomonic symptom | | **Xanthomas** | Eyelids and elbows | ✓ Cholestasis-related lipid deposition | **Mnemonic:** **PBC = Primary (autoimmune), Biliary (cholestasis), Cholangitis (inflammation of ducts)** — but note: intrahepatic cholestasis, NOT extrahepatic obstruction. ### Laboratory Pattern in PBC ```mermaid flowchart TD A[Jaundice + Pruritus]:::outcome --> B{Bile ducts dilated?}:::decision B -->|Yes| C[Extrahepatic obstruction]:::outcome B -->|No| D{AMA positive?}:::decision D -->|Yes| E[PBC]:::action D -->|No| F{ANA/anti-smooth muscle?}:::decision F -->|Yes| G[Autoimmune hepatitis]:::outcome F -->|No| H[Other cholestasis]:::outcome ``` **Clinical Pearl:** AMA positivity is found in 90–95% of PBC patients and is highly specific. AMA-negative PBC exists but is rare and requires exclusion of other causes. ### Why This Is PBC, Not Other Diagnoses 1. **Positive AMA at 1:640** — highly specific for PBC 2. **Normal bile ducts** — excludes obstruction and PSC 3. **Cholestatic biochemistry** (ALP >> transaminases) — intrahepatic cholestasis pattern 4. **Chronic pruritus for 10 years** — classic PBC symptom 5. **Xanthomas** — lipid deposition from chronic cholestasis 6. **Female, non-alcoholic** — typical PBC demographics ### Stages of PBC | Stage | Histology | Clinical Features | |-------|-----------|-------------------| | I | Portal inflammation, granulomas | Asymptomatic or pruritus | | II | Portal fibrosis | Progressive symptoms | | III | Bridging fibrosis | Decompensation risk | | IV | Cirrhosis | Portal hypertension, varices | **High-Yield:** This patient is in Stage II–III (symptomatic with preserved albumin 3.2 g/dL but declining). Ursodeoxycholic acid (UDCA) is first-line therapy; obeticholic acid for UDCA-inadequate response. [cite:Harrison 21e Ch 298]